share_log

EXCLUSIVE: SAB Biotherapeutics Provides Q3 Company Update, Says Received $8.6M From DoD Contract On Nov. 10 For Work Performed

Benzinga Real-time News ·  Nov 15, 2022 08:11
EXCLUSIVE: SAB Biotherapeutics Provides Q3 Company Update, Says Received $8.6M From DoD Contract On Nov. 10 For Work Performed
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment